Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Interest & Investment Income (2022 - 2025)

Historic Interest & Investment Income for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $101000.0.

  • Lucid Diagnostics' Interest & Investment Income rose 2469.14% to $101000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $343000.0, marking a year-over-year decrease of 200.0%. This contributed to the annual value of $322000.0 for FY2024, which is 2405.66% down from last year.
  • Per Lucid Diagnostics' latest filing, its Interest & Investment Income stood at $101000.0 for Q3 2025, which was up 2469.14% from $110000.0 recorded in Q2 2025.
  • In the past 5 years, Lucid Diagnostics' Interest & Investment Income ranged from a high of $136000.0 in Q2 2023 and a low of $1000.0 during Q1 2022
  • Its 4-year average for Interest & Investment Income is $74066.7, with a median of $78000.0 in 2023.
  • As far as peak fluctuations go, Lucid Diagnostics' Interest & Investment Income skyrocketed by 770000.0% in 2023, and later plummeted by 3017.24% in 2024.
  • Over the past 4 years, Lucid Diagnostics' Interest & Investment Income (Quarter) stood at $55000.0 in 2022, then skyrocketed by 70.91% to $94000.0 in 2023, then dropped by 29.79% to $66000.0 in 2024, then soared by 53.03% to $101000.0 in 2025.
  • Its Interest & Investment Income stands at $101000.0 for Q3 2025, versus $110000.0 for Q2 2025 and $66000.0 for Q1 2025.